Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:06.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T21:32:26.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. This is a minor metadata update to the page version.
    Difference
    0.0%
    Check dated 2026-02-12T01:39:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Minor page update: Revision from v3.4.0 to v3.4.1 with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:36:19.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    UI changes include showing the glossary option and minor label/versioning updates (e.g., Last Update Submitted that Met QC Criteria vs met QC Criteria; No FEAR Act data vs data) on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T19:50:32.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:56:08.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.